Neurocrine Biosciences Cash from Financing (TTM) Insights

Neurocrine Biosciences Inc (NBIX)

138.58 -1.67 (-1.19%) USD | NASDAQ | Apr 24, 15:27

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1996. Upgrade now.

Date	Value
December 31, 2023	65.30M
September 30, 2023	54.50M
June 30, 2023	47.10M
March 31, 2023	-232.20M
December 31, 2022	-234.30M
September 30, 2022	-257.10M
June 30, 2022	-261.00M
March 31, 2022	18.40M
December 31, 2021	27.40M
September 30, 2021	-159.40M
June 30, 2021	-161.50M
March 31, 2021	-148.70M
December 31, 2020	-157.80M
September 30, 2020	39.60M
June 30, 2020	47.30M
March 31, 2020	35.80M
December 31, 2019	32.40M
September 30, 2019	21.75M
June 30, 2019	14.14M
March 31, 2019	15.96M
December 31, 2018	29.50M
September 30, 2018	33.35M
June 30, 2018	30.88M
March 31, 2018	531.25M
December 31, 2017	516.65M

Date	Value
September 30, 2017	511.11M
June 30, 2017	509.42M
March 31, 2017	3.859M
December 31, 2016	2.39M
September 30, 2016	3.295M
June 30, 2016	2.706M
March 31, 2016	3.529M
December 31, 2015	276.99M
September 30, 2015	277.76M
June 30, 2015	277.50M
March 31, 2015	276.02M
December 31, 2014	138.73M
September 30, 2014	137.05M
June 30, 2014	139.23M
March 31, 2014	140.58M
December 31, 2013	5.302M
September 30, 2013	5.54M
June 30, 2013	2.997M
March 31, 2013	1.415M
December 31, 2012	83.70M
September 30, 2012	83.44M
June 30, 2012	83.36M
March 31, 2012	83.48M
December 31, 2011	0.286M
September 30, 2011	0.363M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-261.00M

Minimum

Jun 2022

65.30M

Maximum

Dec 2023

-63.60M

Average

18.40M

Median

Mar 2022

Cash from Financing (TTM) Benchmarks